Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve unaudited financial results for the quarter and half year ended September 30 , 2026.

Business Use Date : September 30, 2026 The Corporate Relations Department The Listing Department The BSE Limited The National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400001 Mumbai – 400051 Ref:- Scrip Code:- 500126 Ref:- Scrip Code:- PGHL Dear Sir / Madam, Sub: Intimation of Board Meeting scheduled to be held on November 2, 2026 In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, November 2, 2026, inter alia, to consider and approve unaudited Financial Results for the quarter and half year ended September 30, 2026. Kindly take the same on record. Thanking you, Yours faithfully, For Procter & Gamble Health Limited Flavia Machado Authorized Signatory